Bragg Financial Advisors, Inc Pfizer Inc Transaction History

Bragg Financial Advisors, Inc

$2.4 Billion
Q1 2025

A detailed history of Bragg Financial Advisors, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Bragg Financial Advisors, Inc holds 265,442 shares of PFE stock, worth $6.2 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

265,442

Previous 255,074 4.06%

Holding current value

$6.2 Million

Previous $6.77 Million 0.61%

% of portfolio

0.28%

Previous 0.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$25.01 - $27.13 $259,303 - $281,283	10,368 Added 4.06%	265,442 $6.73 Million
Q4 2024 Feb 13, 2025	SELL	$24.8 - $30.19 $427,353 - $520,234	-17,232 Reduced 6.33%	255,074 $6.77 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $307,109 - $348,020	11,087 Added 4.24%	272,306 $7.88 Million
Q2 2024 Aug 15, 2024	BUY	$25.26 - $29.6 $681,236 - $798,282	26,969 Added 11.51%	261,219 $7.31 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $843,004 - $968,038	-32,561 Reduced 12.2%	234,250 $6.5 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $174,835 - $227,092	-6,691 Reduced 2.45%	266,811 $7.68 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $118,251 - $138,224	3,685 Added 1.37%	273,502 $9.07 Million
Q2 2023 Aug 15, 2023	BUY	$36.12 - $41.79 $404,327 - $467,797	11,194 Added 4.33%	269,817 $9.9 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $134,792 - $175,480	3,422 Added 1.34%	258,623 $10.6 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $292,375 - $381,663	7,003 Added 2.82%	255,201 $13.1 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $46,691 - $56,999	1,067 Added 0.43%	248,198 $10.9 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $113,765 - $134,890	2,445 Added 1.0%	247,131 $13 Million
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $459,284 - $569,110	10,039 Added 4.28%	244,686 $12.7 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $267,999 - $344,267	6,828 Added 3.0%	234,647 $10.1 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $278,733 - $315,758	7,762 Added 3.53%	227,819 $8.92 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $252,347 - $284,596	7,535 Added 3.55%	220,057 $7.97 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $221,470 - $281,619	6,617 Added 3.21%	212,522 $7.82 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $98,583 - $115,661	3,105 Added 1.53%	205,905 $7.56 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $170,629 - $206,999	5,665 Added 2.87%	202,800 $6.63 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $311,953 - $445,713	11,541 Added 6.22%	197,135 $6.43 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $51,750 - $58,729	1,572 Added 0.85%	185,594 $7.27 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $220,249 - $285,599	6,779 Added 3.82%	184,022 $6.61 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $82,280 - $92,382	2,225 Added 1.27%	177,243 $7.68 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $188,962 - $207,606	5,039 Added 2.96%	175,018 $7.43 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $91,212 - $103,992	2,371 Added 1.41%	169,979 $7.42 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $72,283 - $87,675	2,097 Added 1.27%	167,608 $7.39 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $87,232 - $92,998	2,645 Added 1.62%	165,511 $6.01 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $107,153 - $124,313	3,358 Added 2.11%	162,866 $5.78 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $147,275 - $156,264	4,428 Added 2.86%	159,508 $5.78 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $4.81 Million - $5.3 Million	155,080	155,080 $5.54 Million

Others Institutions Holding PFE

# of Institutions

3,369

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $131B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bragg Financial Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bragg Financial Advisors, Inc with notifications on news.

Account

Bragg Financial Advisors, Inc Pfizer Inc Transaction History